These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 35600646)

  • 1. Multistage targeting and dual inhibiting strategies based on bioengineered tumor matrix microenvironment-mediated protein nanocages for enhancing cancer biotherapy.
    Hu F; Deng C; Zhou Y; Liu Y; Zhang T; Zhang P; Zhao Z; Miao H; Zheng W; Zhang W; Wang M; Ma X
    Bioeng Transl Med; 2022 May; 7(2):e10290. PubMed ID: 35600646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple targeting strategies achieve novel protein drug delivery into proapoptosis lung cancer cells by precisely inhibiting survivin.
    Hu F; Yan T; Guo W; Liu Q; Han MH; Liu C; Liu Y; Zheng W; You F; Yang Y; Zhang W; Ma X
    Nanoscale; 2020 May; 12(19):10623-10638. PubMed ID: 32373859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YM155 sensitizes HeLa cells to TRAIL-mediated apoptosis via cFLIP and survivin downregulation.
    Chandrasekaran AP; Poondla N; Ko NR; Oh SJ; Ramakrishna S
    Oncol Lett; 2020 Oct; 20(4):72. PubMed ID: 32863905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of survivin promoter activity by YM155 involves disruption of Sp1-DNA interaction in the survivin core promoter.
    Cheng Q; Ling X; Haller A; Nakahara T; Yamanaka K; Kita A; Koutoku H; Takeuchi M; Brattain MG; Li F
    Int J Biochem Mol Biol; 2012; 3(2):179-97. PubMed ID: 22773958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survivin suppression heightens BZML-induced mitotic catastrophe to overcome multidrug resistance by removing therapy-induced senescent A549/Taxol cells.
    Bai Z; Zhou Y; Ye X; Li Y; Peng Y; Guan Q; Zhang W; Ma L
    Biochim Biophys Acta Mol Cell Res; 2022 Feb; 1869(2):119174. PubMed ID: 34808206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preparation of recombinant HIV-TATm-survivin (T34A) protein and its pro-apoptosis activity to cancer cells in vitro].
    Zheng WY; Ma XY; Wei DZ; Wang JZ; Liu QH; Ma YS; Yang SL
    Sheng Wu Gong Cheng Xue Bao; 2006 Mar; 22(2):285-92. PubMed ID: 16607958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis.
    Blanc-Brude OP; Mesri M; Wall NR; Plescia J; Dohi T; Altieri DC
    Clin Cancer Res; 2003 Jul; 9(7):2683-92. PubMed ID: 12855648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Effects of Sepantronium Bromide (YM155) on MOLT-4 Cell Line Apoptosis Induction and Expression of Critical Genes Involved in Apoptotic Pathways.
    Shojaei Moghadam K; Farshdousti Hagh M; Alivand MR; Fardi M; Movassaghpour AA; Mohammadi A; Moghadasi M; Solali S
    Adv Pharm Bull; 2020 Jan; 10(1):81-87. PubMed ID: 32002365
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of Gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated delivery of the Survivin-T34A mutant.
    Aspe JR; Diaz Osterman CJ; Jutzy JM; Deshields S; Whang S; Wall NR
    J Extracell Vesicles; 2014; 3():. PubMed ID: 24624263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of survivin by YM155 induces apoptosis and growth arrest in hepatocellular carcinoma cells.
    Zhang C; Cao X; Gei Y; Wang Y; Liu G; Cheng G; Liu Q
    Oncol Lett; 2015 Sep; 10(3):1627-1631. PubMed ID: 26622722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant protein TmSm(T34A) can inhibit proliferation and proapoptosis to breast cancer stem cells(BCSCs) by down-regulating the expression of Cyclin D1.
    Ma X; Zhang Y; Kang Y; Li L; Zheng W
    Biomed Pharmacother; 2016 Dec; 84():373-381. PubMed ID: 27668537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of NF-κB/survivin signal pathway on intima hyperplasia of rat carotid balloon injury restenosis model].
    Cheng W; Deng C; Jin L; Shao L; Xu X; Shu C
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Mar; 43(3):248-53. PubMed ID: 26269345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin inhibition by an interacting recombinant peptide, derived from the human ferritin heavy chain, impedes tumor cell growth.
    Weiss A; Brill B; Borghouts C; Delis N; Mack L; Groner B
    J Cancer Res Clin Oncol; 2012 Jul; 138(7):1205-20. PubMed ID: 22426960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YM155 enhances docetaxel efficacy in ovarian cancer.
    Hou LJ; Huang XX; Xu LN; Zhang YY; Zhao N; Ou RY; Li WF; Zhang WJ; Jiang QW; Yang Y; Wei MN; Huang JR; Wang K; Yuan ML; Xing ZH; Shi Z; Yan XJ
    Am J Transl Res; 2018; 10(3):696-708. PubMed ID: 29636860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNA‑218 targets multiple oncogenes and is a therapeutic target for osteosarcoma.
    Sato K; Osaka E; Fujiwara K; Fujii R; Takayama T; Tokuhashi Y; Nakanishi K
    Oncol Rep; 2022 May; 47(5):. PubMed ID: 35293593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic Changes at the
    Mika A; Luelling SE; Pavek A; Nartker C; Heyneman AL; Jones KB; Barrott JJ
    J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30909651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy.
    McKay TR; Bell S; Tenev T; Stoll V; Lopes R; Lemoine NR; McNeish IA
    Oncogene; 2003 Jun; 22(23):3539-47. PubMed ID: 12789262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YM155 exerts potent cytotoxic activity against quiescent (G
    Ookura M; Fujii T; Yagi H; Ogawa T; Kishi S; Hosono N; Shigemi H; Yamauchi T; Ueda T; Yoshida A
    Oncotarget; 2017 Dec; 8(67):111535-111550. PubMed ID: 29340073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of survivin expression on the apoptosis and proliferation of hypoxic human pulmonary arterial smooth muscle cells].
    Zhang S; Liu B; Zhang B; Fan Z
    Zhonghua Jie He He Hu Xi Za Zhi; 2015 Jan; 38(1):45-9. PubMed ID: 25791656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells.
    Taglieri L; De Iuliis F; Giuffrida A; Giantulli S; Silvestri I; Scarpa S
    Oncol Lett; 2017 Sep; 14(3):3832-3838. PubMed ID: 28927154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.